James Francese - 07 Mar 2022 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Sr. VP, Comm. Ops., NA, APAC
Signature
/s/ Samuel Gesten as attorney-in-fact for James Francese
Issuer symbol
STAA
Transactions as of
07 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 17:44:18 UTC
Previous filing
18 Aug 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +5,839 +11% $0.000000 58,469 07 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +12,146 $0.000000 12,146 07 Mar 2022 Common Stock 12,146 $74.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of 5839 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/7/23, 1/3 of the RSUs on 3/7/24, and the remaining 1/3 of the RSUs on 3/7/25.
F2 The options granted become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025.